Legislation and Legislative Advocacy

Learn what happens when high-impact ransomware attacks target third-parties and supply chain vendors and the embedded risk it has to hospitals and health systems.
AHRMM Issues & Legislative (I&L) Committee identifies, reviews and follows the regulatory, environmental, quality of service and standards matters that impact the health care supply chain field. Each I&L Committee member closely monitors an important topic and compiles an update with…
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and level of service. Learn what you can do to get ready for potential changes that could affect your organization.
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the supply chain.
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision making.
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Education Reconciliation Act of 2010 in conjunction with the Patient Protection and Affordable Care Act.
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program to pay hospitals for their actual performance on quality measures, rather than just the reporting of those measures, beginning in fiscal year (FY) 2013. The…